GSK plc
GSK
$40.32
$0.270.67%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 530.19M | -75.48M | 1.48B | 1.33B | 434.76M |
| Total Depreciation and Amortization | 257.41M | 1.24B | 806.10M | 696.16M | 521.71M |
| Total Amortization of Deferred Charges | 270.22M | -- | -- | -- | 252.16M |
| Total Other Non-Cash Items | 2.54B | -524.43M | -475.59M | -38.04M | 626.06M |
| Change in Net Operating Assets | -613.43M | 2.17B | -406.20M | -769.71M | 2.14B |
| Cash from Operations | 2.98B | 2.80B | 1.40B | 1.21B | 3.97B |
| Capital Expenditure | -696.68M | -396.90M | -380.97M | -314.48M | -603.70M |
| Sale of Property, Plant, and Equipment | 78.12M | 1.30M | 2.52M | 1.27M | 8.70M |
| Cash Acquisitions | -83.24M | -5.21M | -41.63M | -915.53M | -2.48M |
| Divestitures | -6.40M | -3.90M | -8.83M | -3.80M | -8.70M |
| Other Investing Activities | -724.85M | -546.55M | 1.40B | 1.04B | 939.08M |
| Cash from Investing | -1.43B | -951.26M | 971.36M | -188.94M | 332.90M |
| Total Debt Issued | 1.34B | -- | -- | -- | -1.41B |
| Total Debt Repaid | -1.15B | -604.00M | -596.00M | -380.00M | -1.41B |
| Issuance of Common Stock | 0.00 | 1.00M | 1.00M | 18.00M | 1.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -783.76M | -796.40M | -822.50M | -720.25M | -705.55M |
| Other Financing Activities | -418.00M | -25.00M | -337.00M | -130.00M | -206.00M |
| Cash from Financing | -1.08B | -1.61B | -2.00B | -1.34B | -4.46B |
| Foreign Exchange rate Adjustments | 8.96M | -44.24M | -10.09M | -24.09M | -42.23M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 480.25M | 193.90M | 367.10M | -342.37M | -201.23M |
